Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

58.93 +0.39 (+0.67%)
Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
38 39 Next >
News headline image
GSK's Jemperli Cancer Drug Hits Primary Goal In Endometrial Cancer Study ↗
GSK plc (NYSE: GSK)  
Via Benzinga
News headline image
Looking Into GSK's Recent Short Interest ↗
 
Via Benzinga
News headline image
Why Is Genetic Medicines-Focused Wave Life Sciences Stock Trading Lower Today? ↗
Wave Life Sciences Ltd (NASDAQ: WVE) has priced its previously announced underwritten public offering of 20 million shares at $5.00 per share with approximately  
Via Benzinga
News headline image
Competition and Optimism: GSK's CEO Walmsley Foresees Growth Despite Competition In RSV Vaccine Market ↗
Emma Walmsley, the Chief Executive Officer of GSK plc (NYSE: GSK), expressed confidence in its respiratory syncytial virus (RSV) vaccine, Arexvy, anticipating sales to surpass £1 billio 
Via Benzinga
News headline image
3 Stocks to Sell for Tax Losses Before the New Year ↗
While no one wants to lose in the market, you can be productive with the red ink through stocks to sell for tax losses. 
Via InvestorPlace
News headline image
3 Great Foreign Companies to Invest in Right Now ↗
The world is a big place, and many great companies are based outside our U.S. borders. 
Via The Motley Fool
News headline image
Price Over Earnings Overview: GSK ↗
 
Via Benzinga
News headline image
Looking Into GSK's Recent Short Interest ↗
 
Via Benzinga
News headline image
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
News headline image
GSK Frames A Comeback For Its Multiple Myeloma Drug Following Encouraging Phase 3 Data ↗
GSK plc (NYSE: GSK) announced headline  
Via Benzinga
News headline image
Merck's Latest Drug For Chronic Cough Faces FDA Pushback ↗
A panel of advisors to the Food and Drug Administration (FDA) reportedly expressed concerns about the efficacy of Merck & Company, Inc.'s (NYSE: 
Via Benzinga
News headline image
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion ↗
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump. 
Via Benzinga
News headline image
Diversifying Your Portfolio With Plant-Based Options ↗
Investors see profit potential in the plant-based market due to rising consumer demand, ESG focus, and the growth of vegan products in various industries, including pharmaceuticals. However, market... 
Via Talk Markets
News headline image
Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B ↗
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over... 
Via Benzinga
News headline image
Current Analysis: GSK Plc ↗
In the pharmaceutical industry, GSK PLC ranks as one of the largest companies by total sales. 
Via Talk Markets
News headline image
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology ↗
Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to... 
Via Benzinga
Topics Intellectual Property Lawsuit
News headline image
European Drug Regulator Recommends Approval Of GSK's Bone Marrow Cancer Med ↗
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a posi 
Via Benzinga
News headline image
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367% ↗
Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth 
Via InvestorPlace
News headline image
3 Healthcare Stocks Getting Help From the Aging Population ↗
America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions. 
Via InvestorPlace
News headline image
3 Top Dividend Stock Picks for Steady Income and Capital Appreciation ↗
Conservative investors will benefit from these top dividend stock picks that are likely to generate significant returns. 
Via InvestorPlace
News headline image
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares ↗
The company issued below-consensus sales views for 2023 and 2024. 
Via Investor's Business Daily
News headline image
GSK Hikes Guidance On The Back Of Its Strong RSV Vaccine Launch ↗
The company is rivaling Pfizer, which also gained approval this year for an RSV vaccine. 
Via Investor's Business Daily
News headline image
GSK Lifts Annual Guidance Again Helped By Strong Launch Of RSV Vaccine, Steady Demand For Shingles Shot ↗
GSK plc (NYSE: GSK) reported Q3 FY23 s 
Via Benzinga
News headline image
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News' ↗
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings. 
Via Benzinga
Topics Economy Stocks
News headline image
Earnings Scheduled For November 1, 2023 ↗
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
News headline image
Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK ↗
GSK plc (NYSE: GSK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have  
Via Benzinga
News headline image
Hope for Endometrial Cancer - GSK Drug Proves Effective in Increasing Survival Rates ↗
GSK plc (NYSE: GSK)  
Via Benzinga
News headline image
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales ↗
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19... 
Via Benzinga
News headline image
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal ↗
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its... 
Via Talk Markets
News headline image
3 Bill Gates Stocks to Buy for Billionaire-Like Returns ↗
Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less. 
Via InvestorPlace
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
38 39 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.